Online citations, reference lists, and bibliographies.
← Back to Search

Lipoprotein And Apolipoprotein Profile In Men With Ischemic Stroke: Role Of Lipoprotein (a), Triglyceride‐Rich Lipoproteins, And Apolipoprotein E Polymorphism

J. Pedro-Botet, M. Sentí, X. Nogués, J. Rubiés-prat, J. Roquer, L. D'olhaberriague, J. Olivé
Published 1992 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Background and Purpose: The role of lipoprotein abnormalities in the development of ischemic cerebrovascular disease has not been sufficiently clarified. The aim of this study was to identify the lipoprotein profile in ischemic cerebrovascular disease and the possible role of apolipoprotein E polymorphism. Methods: The relation between the concentrations of lipoprotein(a), intermediate density lipoproteins, apolipoprotein A-I, apolipoprotein B, apolipoprotein E, and other lipoproteins was studied in 100 men with ischemic cerebrovascular disease (48 atherothrombotic, 28 lacunar, and 24 of unknown type) and in 100 healthy age-matched men as a control group. Results: Patients with ischemic cerebrovascular disease had significantly higher levels of lipoprotein (a), lipids carried by intermediate density lipoproteins, and low density lipoprotein cholesterol and lower levels of high density lipoproteins than control subjects. Patients with atherothrombotic infarction had higher total serum cholesterol and low density lipoprotein cholesterol concentrations than patients with lacunar infarction. To assess lipoprotein abnormalities in normolipidemic subjects, a subgroup of 38 patients with ischemic cerebrovascular disease and 53 control subjects, both with serum cholesterol levels <5.2 mmol/1 (200 mg/dl) and triglycerides <2.3 mmol/1 (200 mg/dl), was analyzed. Serum lipoprotein (a), lipids carried by very low density lipoproteins and intermediate density lipoproteins, and low density lipoprotein triglycerides were significantly higher in normolipidemic patients compared with normolipidemic control subjects, whereas high density lipoprotein cholesterol levels were lower. Apolipoprotein E polymorphism in our ischemic cerebrovascular patients differed from that of the control group, with the ϵ4 allele being more prevalent. Conclusions: Increased serum lipoprotein (a) levels and intermediate density lipoprotein abnormalities together with decreased high density lipoprotein levels are major risk factors for ischemic cerebrovascular disease, even in normocholesterolemic and normotriglyceridemic subjects. Finally, the ϵ4 allele could probably be a predisposing genetic marker for ischemic cerebrovascular disease.
This paper references
http://stroke.ahajournals.org/content
(1556)
10.1172/JCI103182
The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
R. Havel (1955)
10.1177/003693305700200504
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
J. Rankin (1957)
10.1001/ARCHNEUR.1961.00450150030003
Serum cholesterol level in cerebral infarction.
A. Heyman (1961)
10.1016/S0140-6736(67)90012-8
Serum lipids and cerebrovascular disease.
J. N. Cumings (1967)
10.1161/01.STR.5.6.679
Role of Lipids in the Development of Brain Infarction: The Framingham Study
W. Kannel (1974)
10.1016/S0140-6736(75)92376-4
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
G. Miller (1975)
10.1161/01.STR.6.1.77
The Assessment of Insulin, Glucose and Lipids in Ischemic Thrombotic Cerebrovascular Disease
M. Gertler (1975)
10.1016/0003-2697(76)90527-3
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
M. M. Bradford (1976)
A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of proteindye binding
MM Bradford (1976)
10.1016/0002-9343(77)90874-9
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.
T. Gordon (1977)
High density lipoproteins as a protective factor against coronary heart disease
T Gordon (1977)
10.1016/0021-9150(78)90046-1
Dyslipoproteinemia in patients with ischemic cerebro-vascular disease: a study of stroke before the age of 55.
S. Rössner (1978)
10.1212/WNL.28.8.754
The Harvard Cooperative Stroke Registry
J. Mohr (1978)
Soderstrom CE: Dyslipoproteinemia in patients with ischemic cerebrovascular disease: A study of stroke before the age
S Rossner (1978)
10.1016/S0140-6736(79)91375-8
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
P. Avogaro (1979)
10.1016/0021-9150(79)90084-4
Decreased high density lipoprotein-cholesterol levels in male patients with transient ischemic attacks.
C. Sirtori (1979)
10.1111/j.1365-2362.1979.tb00926.x
Reduced high density lipoprotein in stroke: relationship with elevated triglyceride and hypertension
H. Taggart (1979)
Decreased high density lipoprotein cholesterol in male patients with transient ischemic attacks. Atherosclerosis
CR Sirtori (1979)
10.1016/0021-9681(80)90081-8
Transient ischemic attacks (TIAS) and cerebral infarction (CI): a comparison of predisposing factors.
K. Ueda (1980)
10.1016/0003-2697(81)90243-8
Improved techniques for the separation of serum lipoproteins by density gradient ultracentrifugation: visualization by prestaining and rapid separation of serum lipoproteins from small volumes of serum.
A. Terpstra (1981)
10.1001/ARCHNEUR.1981.00510070102026
High-density lipoprotein cholesterol in cerebrovascular disease.
A. Nubiola (1981)
10.1161/01.STR.12.2.167
Lipoprotein Abnormalities in the Pathogenesis of Cerebral Infarction and Transient Ischemic Attack
A. Murai (1981)
10.1136/jnnp.45.2.147
Blood pressure does no predict lacunar infarction.
J. van Gijn (1982)
10.1212/WNL.32.8.871
Lacunar strokes and infarcts
C. Fisher (1982)
10.1056/NEJM198308183090701
Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease.
J. J. Maciejko (1983)
10.1093/IJE/12.1.26
Relation of serum cholesterol and triglycerides to the risk of acute myocardial infarction, cerebral stroke and death in eastern Finnish male population.
J. Salonen (1983)
10.1161/01.ATV.3.4.316
Serum Triglyceride and Risk of Coronary Heart Disease, Stroke, and Total Mortality in Japanese‐American Men
G. Rhoads (1983)
Apolipoprotein AI as a marker of angiographically - assessed coronary artery disease
GL VanderHeiden (1983)
Apolipoprotein AI as a marker of angiographicallyassessed coronary artery disease
J J Maciejko (1983)
STT: Apolipoprotein AI as a marker of angiographicallyassessed coronary artery disease
JJ Maciejko (1983)
10.1016/0021-9681(84)90007-9
Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort.
T. Szatrowski (1984)
10.1016/0021-9150(84)90005-4
Correlation of the extent of coronary occlusion with Apo B levels. Application of a new enzyme immunoassay technique for Apo B.
G. L. Vander Heiden (1984)
10.1161/01.STR.15.2.249
Stroke in South Alabama: Incidence and Diagnostic Features - A Population Based Study
C. Gross (1984)
in south Alabama : Incidence and diagnostic features : A population based study
J Bogousslavsky (1984)
10.1016/0009-8981(85)90269-4
A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application.
M. Eto (1985)
10.1056/NEJM198610233151709
Cigarettes, alcohol, and stroke.
P. Wolf (1986)
10.1001/JAMA.1986.03380200073024
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.
W. Castelli (1986)
10.1093/CLINCHEM/32.5.778
Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease.
H. J. Lenzen (1986)
10.1159/000116033
Apolipoproteins AI, AII and HDL phospholipids but not APO-B are risk indicators for occlusive cerebrovascular disease.
G. Kostner (1986)
10.1161/01.STR.17.5.942
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
G. Zenker (1986)
10.1016/0021-9150(86)90048-1
Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.
A. Murai (1986)
Apolipoprotein Al, All, and HDL phospholipids but not apo-B are risk indicators for occlusive cerebrovascular disease
GM Kostner (1986)
Wolf PA: Cigarettes, alcohol, and stroke
(1986)
Fenotipos de apoprotefna E : Estudio en la poblaci 6 n de Malaga
E Perez-Estrada (1986)
10.1212/WNL.37.3.513
Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke.
G. Juergens (1987)
10.1161/01.CIR.75.1.124
The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.
G. Steiner (1987)
10.1016/0002-8703(87)90636-3
Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease.
R. Krauss (1987)
10.1016/S0140-6736(87)92734-6
INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MEN
R. Krauss (1987)
10.1016/0021-9150(87)90130-4
Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics.
T. Kasama (1987)
Apolipoproteins and lipoproteins in human plasma: an overview.
H. Brewer (1988)
10.1161/01.STR.19.4.423
Relation between blood lipids, lipoproteins, and cerebrovascular atherosclerosis. A review.
G. Tell (1988)
10.1093/CLINCHEM/34.9.1749
Quick method of determining lipoproteins, including those of intermediate density, in serum.
N. Fontanals-Ferrer (1988)
10.1161/01.ATV.8.1.1
Apolipoprotein E polymorphism and atherosclerosis.
J. Davignon (1988)
10.1161/01.STR.19.9.1083
The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.
J. Bogousslavsky (1988)
Sing CF: Apolipoprotein E polymorphism and atherosclerosis
J Davignon (1988)
Apolipoprotein E polymorphism and
J Davignon (1988)
10.1056/NEJM198904063201405
Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.
H. Iso (1989)
10.1093/CLINCHEM/35.7.1380
Lipoprotein(a) quantified by an enzyme-linked immunosorbent assay with monoclonal antibodies.
C. Labeur (1989)
10.1161/01.STR.20.4.448
Plasma lipoproteins in cortical versus lacunar infarction.
R. Adams (1989)
10.1007/978-3-642-83665-7
Cholesterol Transport Systems and Their Relation to Atherosclerosis
A. Steinmetz (1989)
10.1007/978-3-642-83665-7_2
Apolipoprotein E Modulates the Metabolism of Apolipoprotein B Containing Lipoproteins by Multiple Mechanisms
R. Gregg (1989)
10.1161/01.STR.21.9.1251
The fallacy of the lacune hypothesis.
C. Millikan (1990)
10.1161/01.STR.21.3.375
Are hypertension or cardiac embolism likely causes of lacunar infarction?
J. Lodder (1990)
10.1161/01.CIR.82.2.495
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.
M. Austin (1990)
10.1161/01.CIR.81.2.694
Role of triglyceride-rich lipoproteins in progression of atherosclerosis.
R. Havel (1990)
[Apoprotein E phenotypes. A study of the population of Málaga].
E. Pérez Estrada (1990)
10.1161/01.STR.21.4.637
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.
T. Price (1990)
10.1111/j.1600-0404.1990.tb00936.x
Serum lipoprotein pattern variations in dementia and ischemic stroke
F. Giubilei (1990)
Prevalence of apolipoprotein E phenotypes in patients with acute ischemic stroke, (abstract) Stroke 1990;21(suppl I):I-115
F Mahieux (1990)
Warlow CP: Are hypertension or cardiac embolism likely causes of lacunar infarction? Stroke
J Lodder (1990)
: Classification of Cerebrovascular Diseases III
CM Fisher (1990)
Prevalence of apolipoprotein E phenotypes in patients with acute ischemic stroke , ( abstract )
F Mahieux (1990)
Lp(a) lipoprotein abnormalities in cerebrovascular disease and vascular dementia, (abstract) Stroke
K Urakami (1990)
Fenotipos de apoprotefna E: Estudio en la poblaci6n de Malaga
E Perez-Estrada (1990)
Prevalence of apolipoprotein E phenotypes in patients with acute ischemic stroke
F Mahieux (1990)
Lp(a) lipoprotein abnormalities in cerebrovascular disease and vascular dementia, (abstract)
K Urakami (1990)
Lp ( a ) lipoprotein abnormalities in cerebrovascular disease and vascular dementia , ( abstract )
K Asplund (1990)
10.1161/01.STR.22.2.203
Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese.
J. Woo (1991)
The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.
D. Hallman (1991)
10.1159/000108823
Lp(a) Lipoprotein in Patients with Acute Stroke
K. Asplund (1991)
Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol.
E. Boerwinkle (1991)
10.1159/000108899
Topographic Patterns of Cerebral Infarcts
J. Bogousslavsky (1991)
10.1038/KI.1992.204
Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure.
(1992)
10.1161/01.CIR.85.1.30
Lipoprotein Profile in Men With Peripheral Vascular Disease: Role of Intermediate Density Lipoproteins and Apoprotein E Phenotypes
M. Sentí (1992)
All rights reserved. is published by the American Heart Association, 7272 Greenville Avenue
Copyright (1992)
Rubies- Prat J: Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure
M Senti (1992)
Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1-21 by gest on O cber 14, 2017 http://strhajournals.org/ D ow nladed from 1562 Stroke
J Davignon (1992)
Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1-21 by gest on O cber 23, 2017 http://strhajournals.org/ D ow nladed from 1562 Stroke
J Davignon (1992)
Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1-21 by gest on A ril 13, 2017 http://strhajournals.org/ D ow nladed from 1562 Stroke
J Davignon (1992)
Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1-21 by gest on A ril 12, 2017 http://strhajournals.org/ D ow nladed from 1562 Stroke
J Davignon (1992)
Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1-21 by gest on Jne 21, 2017 http://strhajournals.org/ D ow nladed from 1562 Stroke
J Davignon (1992)
Blood pressure does not predict lacunar infarction
J. Gijn
Lipoprotein and apolipoprotein profile in men with ischemic stroke Role of lipoprotein(a), Print ISSN: 0039-2499



This paper is referenced by
10.11603/ijmmr.2413-6077.2021.1.12109
A CROSS SECTIONAL STUDY OF LIPID PROFILE IN NON-DIABETICS WITH STROKE IN URBAN CHITRADURGA
(2021)
10.1038/s41598-021-95141-0
Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis
Pradeep Kumar (2021)
10.31832/smj.849225
İskemik ve Hemorajik İnme Hastalarında Kan Lipid Parametrelerinin Karşılaştırılması ve Mortalite ile İlişkisi
Fettah Eren (2021)
10.13057/smj.v3i2.43779
Hubungan Profil Lipid dan Kadar High-Sensitivity C-Reactive Protein dengan Outcome Pasien Stroke Iskemik Akut
Stefanus Erdana Putra (2020)
10.4103/aian.aian_45_19
Association of APOE Gene Polymorphism with Stroke Patients from Rural Eastern India
H. Ganaie (2019)
10.1016/j.nbd.2018.07.009
Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction
L. Raz (2019)
10.18203/2349-3933.ijam20180063
Study of lipid profile in cases of non-diabetic stroke
Ayaskanta Kar (2018)
DYSLIPIDEMIA IN NON-DIABETIC STROKE
Ashok Singh Rathore (2018)
10.18203/2349-3933.IJAM20173247
Lipoprotein (a) as a risk factor of ischemic stroke: a case-control study
P. More (2017)
10.2174/1389202918666170426165226
Genetic Risk Factors in Cerebrovascular Disorders and Cognitive Deterioration
J. Carril (2017)
10.2174/1389202918666170608093833
Population-based Study of Risk Polymorphisms Associated with Vascular Disorders and Dementia
Óscar Teijido (2017)
10.1142/9789814287142_0007
A Paradox Resolved
V. Hachinski (2017)
10.1177/1179546817731110
Influence of Apolipoprotein E on the Lipid Profile and Postprandial Triglyceride Levels in Brazilian Postmenopausal Women With Artery Disease
L. Tácito (2017)
Genomics and Pharmacogenomics of Cerebrovascular Disorders
J. Carril (2016)
Polimorfizmi u genima za koagulacijske čimbenike i enzime metabolizma homocisteina u djece s moždanim udarom
D. Herak (2016)
Study of atherogenic lipid profile, high sensitive C-reactive protein neurological deficit and short-term outcome in stroke subtypes
Aparna Pandey (2016)
10.1016/B978-0-12-407710-2.00011-4
Stroke as a Complication of General Medical Disorders
P. George (2014)
10.14260/JEMDS/1810
A CLINICAL STUDY OF ISCHAEMIC STROKE WITH REFERENCE TO LIPOPROTEIN (a), LDL AND HDL CHOLESTEROL AS RISK FACTOR
S BasanthKumar (2014)
10.1016/j.eurpsy.2014.03.004
Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression
Y. Zhan (2014)
Alcohol Consumption , Atherosclerosis and Stroke Epidemiologic Follow-up Study in Middle-aged
S. Rantakömi (2013)
10.5772/50257
Genetics of Ischemic Stroke: Emphasis on Candidate-Gene Association Studies
S. Stankovic (2012)
Prevalence of risk factors of ischemic stroke in a local Pakistani population. High-density lipoproteins, an emerging risk factor.
Zeeshan Basharat (2012)
10.1007/s12017-011-8149-7
Triglyceride Level-Influencing Functional Variants of the ANGPTL3, CILP2, and TRIB1 Loci in Ischemic Stroke
L. Járomi (2011)
10.1016/S1474-4422(10)70325-2
Apolipoprotein E in Alzheimer's disease and other neurological disorders
P. Verghese (2011)
Lipid profile in non-diabetic stroke--a study of 100 cases.
K. Sreedhar (2010)
10.1097/YPG.0b013e32833a211a
Depressive symptoms and APOE polymorphisms in an elderly population-based sample
C. García-Peña (2010)
10.3109/10408361003791520
Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors
S. Stanković (2010)
10.3329/BJMS.V9I3.6469
Study of serum non-HDL cholesterol in cerebrovascular disease
S. Parvin (2010)
Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.
S. Anoop (2010)
10.7763/IJET.2010.V2.146
Classification of Neurodegenerative Disorders Based on Major Risk Factors Employing Machine Learning Techniques
S. Joshi (2010)
of Ischemic Stroke Compared With Coronary Heart Disease in Women The Relative Strength of C-Reactive Protein and Lipid Levels as Determinants
Brendan M. Everett (2010)
10.1517/14656560903386276
Stroke pharmacogenomics
A. M. Billeci (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar